Vincerx Pharma, Inc.
General ticker "VINC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.6M (TTM average)
Vincerx Pharma, Inc. does not follow the US Stock Market performance with the rate: -18.8%.
Estimated limits based on current volatility of 4.0%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 42 (+2.4%) as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Dependence on bayer license agreement, Supply chain disruptions, Product liability, Cybersecurity threats, Labor/talent shortage/retention
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.38$, 8.69$]
- 2025-12-31 to 2026-12-31 estimated range: [1.60$, 5.70$]
Financial Metrics affecting the VINC estimates:
- Positive: with PPE of -0.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -113.33 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: 18.93 < Shareholder equity ratio, % of 34.03 <= 41.86
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term VINC quotes
Long-term VINC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $71.19MM | $42.61MM | $31.46MM |
| Operating Income | $-71.19MM | $-42.61MM | $-31.46MM |
| Non-Operating Income | $8.21MM | $2.45MM | $1.39MM |
| R&D Expense | $49.84MM | $28.97MM | $15.49MM |
| Income(Loss) | $-62.98MM | $-40.16MM | $-30.07MM |
| Profit(Loss)* | $-62.98MM | $-40.16MM | $-30.07MM |
| Stockholders Equity | $47.67MM | $11.22MM | $2.72MM |
| Assets | $59.29MM | $18.22MM | $8.01MM |
| Operating Cash Flow | $-59.60MM | $-40.45MM | $-26.13MM |
| Investing Cash Flow | $-40.58MM | $41.50MM | $0.21MM |
| Financing Cash Flow | $0.28MM | $0.11MM | $17.99MM |
| Earnings Per Share** | $-10.86 | $-6.84 | $-5.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.